Zentiva
Zentiva, a leading pharmaceutical company, is headquartered in Prague, Czech Republic, with significant operations across Europe and beyond. Founded in 1998, Zentiva has established itself in the generic and specialty medicines sector, focusing on high-quality, affordable healthcare solutions. The company offers a diverse portfolio of products, including prescription medications, over-the-counter drugs, and biosimilars, distinguished by their commitment to quality and accessibility. Zentiva's innovative approach and dedication to patient needs have positioned it as a trusted name in the industry. With a strong market presence and notable achievements in expanding its product range, Zentiva continues to play a vital role in enhancing healthcare outcomes across various regions, making it a key player in the global pharmaceutical landscape.
DitchCarbon Score
How does Zentiva's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zentiva's score of 30 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Zentiva's reported carbon emissions
In 2023, Zentiva reported total carbon emissions of approximately 81.4 million tonnes CO2e. This figure includes 15.0 million tonnes CO2e from Scope 1 emissions, 13.6 million tonnes CO2e from Scope 2 emissions, and about 52.8 million tonnes CO2e from Scope 3 emissions. Comparatively, in 2022, their total emissions were around 89.7 million tonnes CO2e, indicating a significant reduction of about 8.3 million tonnes CO2e year-on-year. This trend of decreasing emissions is consistent with their 2021 figures, which stood at approximately 75.2 million tonnes CO2e. Zentiva has committed to near-term emissions reduction targets, although they have not set a net-zero target as of now. Their ongoing efforts reflect a commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. The company continues to focus on reducing its greenhouse gas intensity, which was reported at 0.0000258 for Scopes 1 and 2 in 2022 and improved to 0.0000192 in 2023. Overall, Zentiva's emissions data and commitments demonstrate a proactive approach to addressing climate change and reducing their carbon footprint.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 31,972,200 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 15,963,700 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 55,656,900 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Zentiva is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
